Probiotics manufacturer offering contract manufacturing and microbiome R&D services.
| Date | Round | Amount |
|---|---|---|
| Mar 2026 | Series A ELMED Life Sciences raised $2.7M in a Series A from the AgriSURE fund managed by NABVENTURES to scale its microbiome-based solutions. | $2.7M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.